Feedback / Questions
FP008 - FAPON
https://www.prnewswire.com/news-releases/fapon-biopharma-announces-the-enrollment-of-the-first-patient-in-the-phase-i-clinical-trial-of-fp008-a-first-in-class-immunotherapy-for-solid-tumors-302521706.html
Aug 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next